1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Endourology Instruments and Consumables Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Endourology Instruments and Consumables Market Revenue and Volume Forecast, by Product Type
8.1.1. Guidewires
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Ureteral Access Sheaths
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Stone Retrieval Devices (Baskets and Graspers)
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Ureteral Stents
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Dilators and Catheters
8.1.5.1. Market Revenue and Volume Forecast
9.1. Endourology Instruments and Consumables Market Revenue and Volume Forecast, by Procedure Type
9.1.1. Ureteroscopy (Flexible and Rigid)
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Percutaneous Nephrolithotomy (PCNL)
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Retrograde Intrarenal Surgery (RIRS)
9.1.3.1. Market Revenue and Volume Forecast
10.1. Endourology Instruments and Consumables Market Revenue and Volume Forecast, by Application
10.1.1. Kidney Stones (Urolithiasis Management)
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Ureteral Strictures
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Urinary Tract Tumors
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Benign Prostatic Hyperplasia (BPH)
10.1.4.1. Market Revenue and Volume Forecast
11.1. Endourology Instruments and Consumables Market Revenue and Volume Forecast, by End-Use
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Ambulatory Surgical Centers (ASCs)
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Specialty Urology Clinics
11.1.3.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type
12.1.2. Market Revenue and Volume Forecast, by Procedure Type
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by End-Use
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type
12.1.5.2. Market Revenue and Volume Forecast, by Procedure Type
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by End-Use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type
12.1.6.2. Market Revenue and Volume Forecast, by Procedure Type
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by End-Use
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type
12.2.2. Market Revenue and Volume Forecast, by Procedure Type
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by End-Use
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type
12.2.5.2. Market Revenue and Volume Forecast, by Procedure Type
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by End-Use
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type
12.2.6.2. Market Revenue and Volume Forecast, by Procedure Type
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by End-Use
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type
12.2.7.2. Market Revenue and Volume Forecast, by Procedure Type
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by End-Use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type
12.2.8.2. Market Revenue and Volume Forecast, by Procedure Type
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by End-Use
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type
12.3.2. Market Revenue and Volume Forecast, by Procedure Type
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by End-Use
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type
12.3.5.2. Market Revenue and Volume Forecast, by Procedure Type
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by End-Use
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type
12.3.6.2. Market Revenue and Volume Forecast, by Procedure Type
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by End-Use
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type
12.3.7.2. Market Revenue and Volume Forecast, by Procedure Type
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by End-Use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type
12.3.8.2. Market Revenue and Volume Forecast, by Procedure Type
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by End-Use
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type
12.4.2. Market Revenue and Volume Forecast, by Procedure Type
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by End-Use
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type
12.4.5.2. Market Revenue and Volume Forecast, by Procedure Type
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by End-Use
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type
12.4.6.2. Market Revenue and Volume Forecast, by Procedure Type
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by End-Use
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type
12.4.7.2. Market Revenue and Volume Forecast, by Procedure Type
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by End-Use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type
12.4.8.2. Market Revenue and Volume Forecast, by Procedure Type
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by End-Use
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.2. Market Revenue and Volume Forecast, by Procedure Type
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by End-Use
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.5.2. Market Revenue and Volume Forecast, by Procedure Type
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by End-Use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type
12.5.6.2. Market Revenue and Volume Forecast, by Procedure Type
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by End-Use
13.1. Boston Scientific Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerProduct Typeance
13.1.4. Recent Initiatives
13.2. Olympus Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerProduct Typeance
13.2.4. Recent Initiatives
13.3. Karl Storz SE and Co. KG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerProduct Typeance
13.3.4. Recent Initiatives
13.4. Cook Medical
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerProduct Typeance
13.4.4. Recent Initiatives
13.5. Coloplast A/S
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerProduct Typeance
13.5.4. Recent Initiatives
13.6. Richard Wolf GmbH
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerProduct Typeance
13.6.4. Recent Initiatives
13.7. Stryker Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerProduct Typeance
13.7.4. Recent Initiatives
13.8. Medtronic plc
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerProduct Typeance
13.8.4. Recent Initiatives
13.9. Teleflex Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerProduct Typeance
13.9.4. Recent Initiatives
13.10. B. Braun Melsungen AG
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerProduct Typeance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client